
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [SAGE] Sage Therapeutics Inc
Data updated 2025-May-29 (Thursday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-May-29 Thursday
Open | $6.50 | High | $6.60 +1.54% |
---|---|---|---|
Close | $6.52 | Low | $6.46 -0.62% |
Volume | 736 Thousand 1.00x | Volatility | 2.17% |
Change |
+$0.04
+0.62%
|
Streak | ↑ 1 days +0.62% |
20d SMA | $6.79 -4.0% | 50d SMA | $7.30 -10.6% | 100d SMA | $7.24 -9.9% | 200d SMA | $6.97 -6.5% |
RSI | 40 | MACD | -0.01 | ADX | 21.3 | Stochastic Oscillator | 16.5 18.0 |
CCI | -83.1 | ATR | 0.27 | OBV | -43.4 Million | Chaikin A/D | -41.4 Million |
Market Cap | 986 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 11.4 | Price/Book (mrq) | 1.23 | EV/Revenue (ttm) | 2.75 | EV/EBITDA (ttm) | -0.44 |
% Held by Insiders | 12.56% | % Held by Institutions | 95.58% | Shares Short | 8.4 M | Shares Short (prior month) | 9.02 M |
Short Ratio | 8.61 | Short % of Outstanding | 13.97% | Short % of Float | 17.67% | Shares Short Change (mom) | -6.9% |
Revenue/Share (ttm) | $1.45 | Profit Margin (ttm) | 0.00% | Operating Margin (ttm) | -54.23% | EBITDA (ttm) | -545 M |
Diluted EPS (ttm) | $-9.05 | Current Ratio (mrq) | 10.5 | Return on Assets (ttm) | -30.51% | Return on Equity (ttm) | -52.77% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | Operating Cash Flow (ttm) | -541 M | Free Cash Flow (ttm) | -333 M | ||
Choose view type
Daily Performance for Sage Therapeutics Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Sage Therapeutics Inc up to close of 2025-May-29 at $6.52
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
-4.12%
|
-4.4%
|
+0.9%
|
5.6%
|
-0.2%
|
-0.7%
|
1.00x
|
02 Trailing 10-days
|
|
+2.19%
|
-10.1%
|
+2.4%
|
13.8%
|
-2.9%
|
-2.0%
|
0.87x
|
03 Trailing 20-days
|
|
-10.56%
|
-14.5%
|
+2.5%
|
20.0%
|
-4.0%
|
-4.3%
|
0.82x
|
04 Trailing 30-days
|
|
-13.53%
|
-18.7%
|
+2.5%
|
26.1%
|
-7.6%
|
-6.0%
|
0.82x
|
05 Trailing 50-days
|
|
-17.05%
|
-26.0%
|
+6.2%
|
43.5%
|
-10.6%
|
-7.7%
|
0.68x
|
06 Trailing 100-days
|
|
+12.80%
|
-26.0%
|
+19.6%
|
61.7%
|
-9.9%
|
-9.2%
|
1.28x
|
07 Trailing 200-days
|
|
-18.60%
|
-26.0%
|
+41.1%
|
90.7%
|
-6.5%
|
-22.6%
|
1.00x
|
08 Month-to-date
|
|
-10.56%
|
-14.5%
|
+2.5%
|
20.0%
|
|
|
|
09 Quarter-to-date
|
|
-17.99%
|
-18.7%
|
+6.2%
|
30.6%
|
|
|
|
10 Year-to-date
|
|
+20.07%
|
-26.0%
|
+20.7%
|
63.1%
|
|
|
|
11 Trailing 52-weeks
|
|
-39.96%
|
-51.6%
|
+41.1%
|
191.6%
|
|
|
|
3-month Performance Benchmarks for Sage Therapeutics Inc:
Related to Sage Therapeutics Inc
Information for Sage Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-29 on Google
SEC Reports : Quarterly reports around 2025-May-29 on SEC Edgar
Compare Sage Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Sage Therapeutics Inc
Industry : Biotechnology industry performance which includes Sage Therapeutics Inc